Logos Global Management LP Q2 2024 Filing
Filed August 14, 2024
Portfolio Value
$1.2B
Holdings
50
Report Date
Q2 2024
Filing Type
13F-HR
All Holdings (50 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | XBISPDR SER TR | 2,000,000 | $185.4T | 15053306.01% | Put |
| 2 | SRPTSAREPTA THERAPEUTICS INC | 650,000 | $102.7T | 8337690.26% | Call |
| 3 | APLSAPELLIS PHARMACEUTICALS INC | 2,400,000 | $92.1T | 7474207.55% | Call |
| 4 | GPCRSTRUCTURE THERAPEUTICS INC | 1,550,000 | $60.9T | 4941603.69% | Call |
| 5 | IDYAIDEAYA BIOSCIENCES INC | 1,700,000 | $59.7T | 4845683.72% | |
| 6 | ARGXARGENX SE | 135,000 | $58.1T | 4713222.42% | |
| 7 | MRUSMERUS N V | 850,000 | $50.3T | 4083154.46% | |
| 8 | RVMDREVOLUTION MEDICINES INC | 1,200,000 | $46.6T | 3780943.63% | |
| 9 | IRONDISC MEDICINE INC | 925,000 | $41.7T | 3384578.60% | |
| 10 | OCULOCULAR THERAPEUTIX INC | 5,150,000 | $35.2T | 2859819.64% | |
| 11 | OLMAOLEMA PHARMACEUTICALS INC | 3,208,875 | $34.7T | 2818742.35% | |
| 12 | VERAVERA THERAPEUTICS INC | 950,000 | $34.4T | 2790406.54% | |
| 13 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 750,000 | $33.0T | 2677275.37% | |
| 14 | JANXJANUX THERAPEUTICS INC | 750,000 | $31.4T | 2550626.91% | |
| 15 | XNCRXENCOR INC | 1,500,000 | $28.4T | 2305245.52% | |
| 16 | SLNSILENCE THERAPEUTICS PLC | 1,476,061 | $28.0T | 2276843.71% | |
| 17 | ANNXANNEXON INC | 4,800,000 | $23.5T | 1909469.08% | Call |
| 18 | AKROAKERO THERAPEUTICS INC | 800,000 | $18.8T | 1523678.39% | |
| 19 | DSGNDESIGN THERAPEUTICS INC | 5,032,501 | $16.9T | 1368686.49% | |
| 20 | IMVTIMMUNOVANT INC | 575,000 | $15.2T | 1232386.93% | |
| 21 | NUVLNUVALENT INC | 195,000 | $14.8T | 1200944.02% | |
| 22 | XENEXENON PHARMACEUTICALS INC | 375,000 | $14.6T | 1187024.87% | |
| 23 | ISIIONIS PHARMACEUTICALS INC | 300,000 | $14.3T | 1160781.84% | |
| 24 | STOKSTOKE THERAPEUTICS INC | 1,050,000 | $14.2T | 1151648.54% | |
| 25 | ERASERASCA INC | 5,900,000 | $13.9T | 1130418.69% | |
| 26 | ELVNENLIVEN THERAPEUTICS INC | 595,000 | $13.9T | 1128888.35% | |
| 27 | SYRESPYRE THERAPEUTICS INC | 575,000 | $13.5T | 1097477.91% | |
| 28 | ENGNENGENE HOLDINGS INC | 1,200,000 | $11.3T | 918688.44% | |
| 29 | CYBNEURCYBIN INC | 40,000,000 | $10.8T | 880044.42% | |
| 30 | SKYESKYE BIOSCIENCE INC | 1,301,518 | $10.4T | 846365.60% | |
| 31 | —ELEVATION ONCOLOGY INC | 3,850,000 | $10.4T | 843917.14% | |
| 32 | DYNDYNE THERAPEUTICS INC | 265,000 | $9.4T | 759229.10% | |
| 33 | FULCFULCRUM THERAPEUTICS INC | 1,500,000 | $9.3T | 755019.66% | Call |
| 34 | BHVNBIOHAVEN LTD | 250,000 | $8.7T | 704482.06% | |
| 35 | RLAYRELAY THERAPEUTICS INC | 1,300,000 | $8.5T | 688123.30% | |
| 36 | TRVITREVI THERAPEUTICS INC | 2,800,000 | $8.3T | 677406.89% | |
| 37 | RCKTROCKET PHARMACEUTICALS INC | 350,000 | $7.5T | 611768.89% | |
| 38 | CMPSCOMPASS PATHWAYS PLC | 1,159,030 | $7.0T | 568338.29% | |
| 39 | LCTXLINEAGE CELL THERAPEUTICS IN | 4,700,000 | $4.7T | 380538.84% | |
| 40 | ATYRATYR PHARMA INC | 3,000,000 | $4.7T | 379945.38% | |
| 41 | CATBUSDASTRIA THERAPEUTICS INC | 500,000 | $4.5T | 369391.34% | |
| 42 | NXTCNEXTCURE INC | 2,500,000 | $4.0T | 322710.02% | |
| 43 | NMRANEUMORA THERAPEUTICS INC. | 300,000 | $2.9T | 239414.30% | |
| 44 | ALLKGUSDALLAKOS INC | 2,900,000 | $2.9T | 235436.24% | |
| 45 | AVU0ADVERUM BIOTECHNOLOGIES INC | 416,666 | $2.9T | 232053.18% | |
| 46 | APLTAPPLIED THERAPEUTICS INC | 600,000 | $2.7T | 216106.11% | |
| 47 | RNACCARTESIAN THERAPEUTICS INC | 90,000 | $2.4T | 197352.40% | |
| 48 | UNCYUNICYCIVE THERAPEUTICS INC | 3,469,927 | $1.7T | 141162.70% | |
| 49 | IOBTIO BIOTECH INC | 493,827 | $577.8B | 46906.85% | |
| 50 | NUVB/WSNUVATION BIO INC | 66,666 | $10.7B | 866.00% |